In a landmark campaign, Novo Nordisk India Private Limited has set a new record for the maximum number of pledges signed by healthcare professionals (HCPs) in support of insulin usage. A total of 8,328 doctors from across India participated in the campaign titled “#FromFeartoFreedom,” pledging their commitment to advocating and appreciating the use of insulin in diabetes management.
The digital pledges were signed on a specially designed portal created for the campaign between July 17, 2023 and August 5, 2023. This nationwide initiative aimed to raise awareness and encourage better diabetes care, focusing on empowering patients to live healthier lives through proper insulin therapy.
Dr. [Name of Representative], spokesperson from Novo Nordisk India, expressed their gratitude: “We are thrilled by the overwhelming response from the healthcare community. This is a testament to the collective commitment to improving diabetes care across India. The support shown by over 8,000 doctors is inspiring, and we believe it will lead to better health outcomes for patients.”
This initiative is a vital step in ensuring that insulin, a critical component in managing diabetes, is recognized for its life-saving potential and accessibility. The campaign’s success reflects the growing collaboration between healthcare professionals and organizations like Novo Nordisk to combat diabetes in India.
